These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20449764)

  • 1. In situ artificial membrane permeation assay under hydrodynamic control: permeability-pH profiles of warfarin and verapamil.
    Velický M; Bradley DF; Tam KY; Dryfe RA
    Pharm Res; 2010 Aug; 27(8):1644-58. PubMed ID: 20449764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ artificial membrane permeation assay under hydrodynamic control: correlation between drug in vitro permeability and fraction absorbed in humans.
    Velický M; Tam KY; Dryfe RA
    Eur J Pharm Sci; 2011 Oct; 44(3):299-309. PubMed ID: 21864679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeation of a fully ionized species across a polarized supported liquid membrane.
    Velický M; Tam KY; Dryfe RA
    Anal Chem; 2012 Mar; 84(5):2541-7. PubMed ID: 22283849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permeation prediction of M100240 using the parallel artificial membrane permeability assay.
    Hwang KK; Martin NE; Jiang L; Zhu C
    J Pharm Pharm Sci; 2003; 6(3):315-20. PubMed ID: 14738711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAMPA--a drug absorption in vitro model. 5. Unstirred water layer in iso-pH mapping assays and pKa(flux)--optimized design (pOD-PAMPA).
    Ruell JA; Tsinman KL; Avdeef A
    Eur J Pharm Sci; 2003 Dec; 20(4-5):393-402. PubMed ID: 14659483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a unified model of passive drug permeation I: origins of the unstirred water layer with applications to ionic permeation.
    Ghosh A; Scott DO; Maurer TS
    Eur J Pharm Sci; 2014 Feb; 52():109-24. PubMed ID: 24211511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Mechanistic Study of Drug Mass Transport from Supersaturated Solutions Across PAMPA Membranes.
    Hate SS; Mosquera-Giraldo LI; Taylor LS
    J Pharm Sci; 2022 Jan; 111(1):102-115. PubMed ID: 34237298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the artificial membrane permeability of drugs by digital simulation.
    Nakamura M; Osakai T
    Eur J Pharm Sci; 2016 Aug; 91():154-61. PubMed ID: 27334569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic passive permeability assay using nanoliter droplet interface lipid bilayers.
    Nisisako T; Portonovo SA; Schmidt JJ
    Analyst; 2013 Nov; 138(22):6793-800. PubMed ID: 24056299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hydrodynamic approach to the measurement of the permeability of small molecules across artificial membranes.
    Molloy BJ; Tam KY; Matthew Wood J; Dryfe RA
    Analyst; 2008 May; 133(5):655-9. PubMed ID: 18427688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug delivery.
    Webb MS; Wheeler JJ; Bally MB; Mayer LD
    Biochim Biophys Acta; 1995 Sep; 1238(2):147-55. PubMed ID: 7548129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAMPA--a drug absorption in vitro model 11. Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates.
    Avdeef A; Nielsen PE; Tsinman O
    Eur J Pharm Sci; 2004 Aug; 22(5):365-74. PubMed ID: 15265506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of DMPC and DSPC lipids for verapamil and naproxen permeability studies by PAMPA.
    Alvarez-Figueroa MJ; Contreras-Garrido BC; Soto-Arriaza MA
    Drug Dev Ind Pharm; 2015 Apr; 41(4):658-62. PubMed ID: 24568608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeation characteristics of a hydrophilic basic compound across a bio-mimetic artificial membrane.
    Sugano K; Nabuchi Y; Machida M; Asoh Y
    Int J Pharm; 2004 May; 275(1-2):271-8. PubMed ID: 15081157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
    Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
    J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unstirrable water layer is unstirrable because it does not exist.
    Scherrer RA
    Chem Biodivers; 2009 Nov; 6(11):1917-22. PubMed ID: 19937829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rise of PAMPA.
    Avdeef A
    Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):325-42. PubMed ID: 16922646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immobilized Artificial Membrane HPLC Derived Parameters vs PAMPA-BBB Data in Estimating in Situ Measured Blood-Brain Barrier Permeation of Drugs.
    Grumetto L; Russo G; Barbato F
    Mol Pharm; 2016 Aug; 13(8):2808-16. PubMed ID: 27377191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.